Your browser doesn't support javascript.
loading
Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study.
Ayano, Masahiro; Kimoto, Yasutaka; Mitoma, Hiroki; Akahoshi, Mitsuteru; Ono, Nobuyuki; Arinobu, Yojiro; Akashi, Koichi; Horiuchi, Takahiko; Niiro, Hiroaki.
Afiliación
  • Ayano M; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Kimoto Y; Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan.
  • Mitoma H; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Akahoshi M; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Ono N; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Arinobu Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Horiuchi T; Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan.
  • Niiro H; Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Ther Adv Musculoskelet Dis ; 14: 1759720X221096367, 2022.
Article en En | MEDLINE | ID: mdl-35586513

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Año: 2022 Tipo del documento: Article País de afiliación: Japón